Agape ATP CorpATPCEarnings & Financial Report
Nasdaq · Health Care · Services-Health Services
Revenue
$331.3K
Gross Profit
$184.2K
Operating Profit
$-548.1K
Net Profit
$-509.6K
Gross Margin
55.6%
Operating Margin
-165.4%
Net Margin
-153.8%
YoY Growth
-6.8%
EPS
$-0.13
Agape ATP Corp Q3 FY2024 Financial Summary
Agape ATP Corp reported revenue of $331.3K (down 6.8% YoY) for Q3 FY2024, with a net profit of $-509.6K (down 55.8% YoY) (-153.8% margin). Cost of goods sold was $147.1K, operating expenses totaled $732.3K.
Key Financial Metrics
| Total Revenue | $331.3K |
|---|---|
| Net Profit | $-509.6K |
| Gross Margin | 55.6% |
| Operating Margin | -165.4% |
| Report Period | Q3 FY2024 |
Agape ATP Corp Annual Revenue by Year
Agape ATP Corp annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.5M).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.5M |
| 2024 | $1.3M |
| 2023 | $1.4M |
| 2022 | $1.9M |
Agape ATP Corp Quarterly Revenue & Net Profit History
Agape ATP Corp results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $399.1K | +10.9% | $-376.9K | -94.4% |
| Q3 FY2025 | $370.6K | +11.9% | $-586.8K | -158.3% |
| Q2 FY2025 | $465.5K | +48.7% | $-617.1K | -132.6% |
| Q1 FY2025 | $289.0K | -9.3% | $-698.9K | -241.8% |
| Q4 FY2024 | $359.8K | -8.0% | $-808.4K | -224.7% |
| Q3 FY2024 | $331.3K | -6.8% | $-509.6K | -153.8% |
| Q2 FY2024 | $313.0K | +3.0% | $-442.7K | -141.4% |
| Q1 FY2024 | $318.6K | -16.3% | $-709.7K | -222.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $318643 | $313039 | $331289 | $359776 | $289037 | $465499 | $370593 | $399133 |
| YoY Growth | -16.3% | 3.0% | -6.8% | -8.0% | -9.3% | 48.7% | 11.9% | 10.9% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.8M | $4.3M | $4.0M | $3.2M | $25.2M | $24.7M | $24.4M | $24.6M |
| Liabilities | $1.1M | $1.0M | $1.2M | $1.3M | $1.2M | $1.3M | $1.6M | $2.2M |
| Equity | $3.7M | $3.2M | $2.7M | $1.9M | $24.0M | $23.4M | $22.8M | $22.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.2M | $-412540 | $-424880 | $-645335 | $-1.5M | $-494458 | $-256742 | $-208348 |